Aclaris Therapeutics(ACRS)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

Aclaris Therapeutics(ACRS)

盘后1.190.000.00%19:51 EDT

1.19+0.01+0.85%

社区社区
资讯资讯
资料资料
公告公告

- 最新
- 推荐
公司概况
公司名称
Aclaris Therapeutics
所属市场
NASDAQ
成立日期
- -
员工人数
- -
办公地址
- -
公司网址
http://www.aclaristx.com
邮政编码
- -
联系电话
- -
联系传真
- -
公司概况
Aclaris Therapeutics, Inc.于2012年7月在美国特拉华州成立。该公司是一家临床阶段的生物制药公司，专注于开发免疫炎症疾病的新型候选药物。
- 05-07
  季度报告
  Form 10-Q - Quarterly report [Sections 13 or 15(d)]
  Form 10-Q - Quarterly report [Sections 13 or 15(d)]
- 05-07
  员工持股计划
  Form S-8 - Securities to be offered to employees in employee benefit plans
  Form S-8 - Securities to be offered to employees in employee benefit plans
- 05-07
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report
- 03-19
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report
- 02-27
  年度报告
  Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
  Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
- 02-27
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report
- 02-14
  超过5%披露
  Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
  Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
- 02-14
  超过5%披露
  Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
  Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
- 02-14
  超过5%披露
  Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
  Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
- 02-14
  超过5%披露
  Form SC 13G - Statement of acquisition of beneficial ownership by individuals
  Form SC 13G - Statement of acquisition of beneficial ownership by individuals
- 02-14
  超过5%披露
  Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
  Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
- 02-14
  超过5%披露
  Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
  Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
- 02-14
  超过5%披露
  Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
  Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
- 02-14
  超过5%披露
  Form SC 13G - Statement of acquisition of beneficial ownership by individuals
  Form SC 13G - Statement of acquisition of beneficial ownership by individuals
- 02-13
  超过5%披露
  Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
  Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]

分时
5日
日
周
月

最高

1.20

今开

1.20

量比

0.78

最低

1.15

昨收

1.18

换手率

0.88%

热议股票

关于我们·老虎社区守则·老虎社区账号管理规范·老虎社区服务协议·老虎社区隐私政策

公司名称：北京至简风宜信息技术有限公司

违法和不良信息投诉：010-5681-3562（工作时间9:30-18:30）

邮箱：service@laohu8.com

老虎社区侵权投诉指引

中国互联网举报中心·北京互联网举报中心

网络谣言曝光台·扫黄打非举报中心

网络110报警服务

© 2018-2024 老虎社区版权所有

营业执照：91110105MA01A4U55R

ICP备：京ICP备18016422号

网安备：京公网安备11010502036490

qrcode

关注我们

{"pagemeta":{"title":"Aclaris Therapeutics(ACRS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Aclaris Therapeutics(ACRS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Aclaris Therapeutics,ACRS,Aclaris Therapeutics股票,Aclaris Therapeutics股票老虎,Aclaris Therapeutics股票老虎国际,Aclaris Therapeutics行情,Aclaris Therapeutics股票行情,Aclaris Therapeutics股价,Aclaris Therapeutics股市,Aclaris Therapeutics股票价格,Aclaris Therapeutics股票交易,Aclaris Therapeutics股票购买,Aclaris Therapeutics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Aclaris Therapeutics(ACRS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Aclaris Therapeutics(ACRS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}},"tab":"community","symbol":"ACRS","data":{"stockData":{"symbol":"ACRS","market":"US","secType":"STK","nameCN":"Aclaris Therapeutics","latestPrice":1.19,"timestamp":1715976000000,"preClose":1.18,"halted":0,"volume":446399,"hourTrading":{"tag":"盘后","latestPrice":1.19,"preClose":1.19,"latestTime":"19:51 EDT","volume":2399,"amount":2855.269,"timestamp":1715989868936},"delay":0,"floatShares":50922830,"shares":71264786,"eps":-1.092844,"marketStatus":"已收盘","marketStatusCode":5,"change":0.01,"latestTime":"05-17 16:00:00 EDT","open":1.2,"high":1.2,"low":1.15,"amount":528213.4463235,"amplitude":0.042373,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.092844,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1716192000000},"adr":0,"listingDate":1444190400000,"adjPreClose":1.18,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":1.2195,"preClose":1.18,"latestTime":"09:19 EDT","volume":1399,"amount":1665.4319954,"timestamp":1715951973172},"postHourTrading":{"tag":"盘后","latestPrice":1.19,"preClose":1.19,"latestTime":"19:51 EDT","volume":2399,"amount":2855.269,"timestamp":1715989868936},"volumeRatio":0.783401},"tweetData":{"bottom":false,"list":[{"cardType":"TWEET","cardId":"TWEET.350353674","cardData":[{"tweetId":"350353674","author":{"authorId":"165515297364160","name":"鹰掠资本","avatar":"https://static.tigerbbs.com/ae79133876eec0b28f180a733391ec2d","userType":1,"introduction":"","crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[],"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"digest":"<a href=\"https://laohu8.com/S/ACRS\">$Aclaris Therapeutics(ACRS)$</a>孙子，**美利奸还不下来","plainDigest":"$Aclaris Therapeutics(ACRS)$孙子，**美利奸还不下来","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1616162309398,"gmtModify":1616162309398,"symbols":["ACRS"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":1,"images":[{"url":"https://static.tigerbbs.com/96957f293d11f62010dc6714ed84183b","width":"1080","height":"1400"}],"repostCount":0,"viewCount":619,"likeCount":1,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/350353674","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":48,"authorId":"165515297364160"}]},{"cardType":"TWEET","cardId":"TWEET.310522561","cardData":[{"tweetId":"310522561","author":{"authorId":"3561599688087068","name":"老黄师傅","avatar":"https://static.tigerbbs.com/cf7238cc549ff0b91b23cf160834f7c2","userType":1,"introduction":"","crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[],"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"digest":"<a href=\"https://laohu8.com/S/ACRS\">$Aclaris Therapeutics(ACRS)$</a>又有人开始不眠之夜","plainDigest":"$Aclaris Therapeutics(ACRS)$又有人开始不眠之夜","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1611334107953,"gmtModify":1703750032008,"symbols":["ACRS"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":0,"images":[],"repostCount":0,"viewCount":1106,"likeCount":2,"liked":false,"collected":false,"commentCount":2,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/310522561","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":45,"authorId":"3561599688087068"}]},{"cardType":"TWEET","cardId":"TWEET.310668428","cardData":[{"tweetId":"310668428","author":{"authorId":"3530072543615030","name":"大韭菜盒子","avatar":"https://static.tigerbbs.com/a2277a8ca4e10763026e63aff57dad69","userType":1,"introduction":"","crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"digest":"<a href=\"https://laohu8.com/S/ACRS\">$Aclaris Therapeutics(ACRS)$</a>今天有戏到15不？大盘都这么低了。你也别挺着了","plainDigest":"$Aclaris Therapeutics(ACRS)$今天有戏到15不？大盘都这么低了。你也别挺着了","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1611324702664,"gmtModify":1703749726603,"symbols":["ACRS"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":0,"images":[],"repostCount":0,"viewCount":1691,"likeCount":4,"liked":false,"collected":false,"commentCount":6,"hotComments":[{"id":"3369812","author":{"authorId":"3561599688087068","name":"老黄师傅","avatar":"https://static.tigerbbs.com/cf7238cc549ff0b91b23cf160834f7c2","userType":1,"introduction":"","crmLevel":2,"crmLevelSwitch":0,"starInvestorFlag":false},"content":"干，搞了三天了，真烦","plainContent":"干，搞了三天了，真烦","likeCount":0,"commentType":"valid","coins":0},{"id":"3370632","author":{"authorId":"3561599688087068","name":"老黄师傅","avatar":"https://static.tigerbbs.com/cf7238cc549ff0b91b23cf160834f7c2","userType":1,"introduction":"","crmLevel":2,"crmLevelSwitch":0,"starInvestorFlag":false},"content":"不好玩，有钱再空","plainContent":"不好玩，有钱再空","likeCount":0,"commentType":"valid","coins":0}],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/310668428","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":69,"authorId":"3530072543615030"}]},{"cardType":"TWEET","cardId":"TWEET.310333646","cardData":[{"tweetId":"310333646","author":{"authorId":"3483669283508638","name":"我就是阿硕","avatar":"https://static.tigerbbs.com/ef3a6f12848da8815606073e69dae4be","userType":1,"introduction":"","crmLevel":8,"crmLevelSwitch":0,"individualDisplayBadges":[],"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"digest":"<a href=\"https://laohu8.com/S/ACRS\">$Aclaris Therapeutics(ACRS)$</a>靠，还不下来！[笑哭]&nbsp;","plainDigest":"$Aclaris Therapeutics(ACRS)$靠，还不下来！[笑哭]","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1611248276285,"gmtModify":1703749248186,"symbols":["ACRS"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":0,"images":[],"repostCount":0,"viewCount":2554,"likeCount":0,"liked":false,"collected":false,"commentCount":14,"hotComments":[{"id":"3364942","author":{"authorId":"3499383985770734","name":"刘夏米","avatar":"https://static.tigerbbs.com/8cc195bb43dc15ebc7b7ab9daa9083d4","userType":1,"introduction":"","crmLevel":6,"crmLevelSwitch":0,"starInvestorFlag":false},"content":"20日富途有新闻，增发价格17.5。老虎新闻总是慢半拍的 [捂脸]","plainContent":"20日富途有新闻，增发价格17.5。老虎新闻总是慢半拍的 [捂脸]","likeCount":0,"commentType":"valid","coins":0},{"id":"3364846","author":{"authorId":"3561599688087068","name":"老黄师傅","avatar":"https://static.tigerbbs.com/cf7238cc549ff0b91b23cf160834f7c2","userType":1,"introduction":"","crmLevel":2,"crmLevelSwitch":0,"starInvestorFlag":false},"content":"晚上合适就卖了，不玩了","plainContent":"晚上合适就卖了，不玩了","likeCount":0,"commentType":"valid","coins":0},{"id":"3364779","author":{"authorId":"3530072543615030","name":"大韭菜盒子","avatar":"https://static.tigerbbs.com/a2277a8ca4e10763026e63aff57dad69","userType":1,"introduction":"","crmLevel":1,"crmLevelSwitch":0,"starInvestorFlag":false},"content":"根本没空头","plainContent":"根本没空头","likeCount":0,"commentType":"valid","coins":0}],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":true,"shareLink":"https://laohu8.com/post/310333646","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":45,"authorId":"3483669283508638"}]},{"cardType":"TWEET","cardId":"TWEET.310330395","cardData":[{"tweetId":"310330395","author":{"authorId":"3530072543615030","name":"大韭菜盒子","avatar":"https://static.tigerbbs.com/a2277a8ca4e10763026e63aff57dad69","userType":1,"introduction":"","crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"digest":"<a href=\"https://laohu8.com/S/ACRS\">$Aclaris Therapeutics(ACRS)$</a>没见过这么墨迹的股。要跌赶紧的","plainDigest":"$Aclaris Therapeutics(ACRS)$没见过这么墨迹的股。要跌赶紧的","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1611247863517,"gmtModify":1703749245275,"symbols":["ACRS"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":0,"images":[],"repostCount":0,"viewCount":542,"likeCount":0,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/310330395","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":56,"authorId":"3530072543615030"}]},{"cardType":"TWEET","cardId":"TWEET.310330969","cardData":[{"tweetId":"310330969","author":{"authorId":"3561599688087068","name":"老黄师傅","avatar":"https://static.tigerbbs.com/cf7238cc549ff0b91b23cf160834f7c2","userType":1,"introduction":"","crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[],"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"digest":"<a href=\"https://laohu8.com/S/ACRS\">$Aclaris Therapeutics(ACRS)$</a>真累","plainDigest":"$Aclaris Therapeutics(ACRS)$真累","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1611247847051,"gmtModify":1703749244763,"symbols":["ACRS"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":0,"images":[],"repostCount":0,"viewCount":807,"likeCount":1,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/310330969","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":31,"authorId":"3561599688087068"}]},{"cardType":"TWEET","cardId":"TWEET.310391680","cardData":[{"tweetId":"310391680","author":{"authorId":"3561599688087068","name":"老黄师傅","avatar":"https://static.tigerbbs.com/cf7238cc549ff0b91b23cf160834f7c2","userType":1,"introduction":"","crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[],"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"digest":"<a href=\"https://laohu8.com/S/ACRS\">$Aclaris Therapeutics(ACRS)$</a>你妹，无语的拉","plainDigest":"$Aclaris Therapeutics(ACRS)$你妹，无语的拉","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1611246651840,"gmtModify":1703749236584,"symbols":["ACRS"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":0,"images":[],"repostCount":0,"viewCount":639,"likeCount":1,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/310391680","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":40,"authorId":"3561599688087068"}]},{"cardType":"TWEET","cardId":"TWEET.310965898","cardData":[{"tweetId":"310965898","author":{"authorId":"3561599688087068","name":"老黄师傅","avatar":"https://static.tigerbbs.com/cf7238cc549ff0b91b23cf160834f7c2","userType":1,"introduction":"","crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[],"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"digest":"<a href=\"https://laohu8.com/S/ACRS\">$Aclaris Therapeutics(ACRS)$</a>又往上拉了","plainDigest":"$Aclaris Therapeutics(ACRS)$又往上拉了","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1611241774014,"gmtModify":1703749158924,"symbols":["ACRS"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":0,"images":[],"repostCount":0,"viewCount":1226,"likeCount":2,"liked":false,"collected":false,"commentCount":4,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/310965898","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":37,"authorId":"3561599688087068"}]},{"cardType":"TWEET","cardId":"TWEET.310986198","cardData":[{"tweetId":"310986198","author":{"authorId":"3547702836420032","name":"风轻云淡雪飞","avatar":"https://static.tigerbbs.com/78ffd766cdec6eb502446e7262c03c4c","userType":1,"introduction":"","crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"digest":"<a href=\"https://laohu8.com/S/ACRS\">$Aclaris Therapeutics(ACRS)$</a>看盘型，高开低走，资金外流，割韭菜了","plainDigest":"$Aclaris Therapeutics(ACRS)$看盘型，高开低走，资金外流，割韭菜了","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1611241147114,"gmtModify":1703749143402,"symbols":["ACRS"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":0,"images":[],"repostCount":0,"viewCount":820,"likeCount":1,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/310986198","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":60,"authorId":"3547702836420032"}]},{"cardType":"TWEET","cardId":"TWEET.337410842","cardData":[{"tweetId":"337410842","author":{"authorId":"3565866229126097","name":"韭菜小萌新","avatar":"https://static.tigerbbs.com/757150234f1e50e6d2ad5d4a78c6068d","userType":1,"introduction":"","crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[],"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"digest":"<a href=\"https://laohu8.com/S/ACRS\">$Aclaris Therapeutics(ACRS)$</a>盘后之所以拉升大多是空军比较慌的的在平仓，憨憨操作，今晚盘还得降十个点以上[真香]&nbsp;","plainDigest":"$Aclaris Therapeutics(ACRS)$盘后之所以拉升大多是空军比较慌的的在平仓，憨憨操作，今晚盘还得降十个点以上[真香]","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1611184417586,"gmtModify":1703748631477,"symbols":["ACRS"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":0,"images":[],"repostCount":0,"viewCount":1243,"likeCount":3,"liked":false,"collected":false,"commentCount":1,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/337410842","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":105,"authorId":"3565866229126097"}]},{"cardType":"TWEET","cardId":"TWEET.337496622","cardData":[{"tweetId":"337496622","author":{"authorId":"3547702836420032","name":"风轻云淡雪飞","avatar":"https://static.tigerbbs.com/78ffd766cdec6eb502446e7262c03c4c","userType":1,"introduction":"","crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"digest":"<a href=\"https://laohu8.com/S/ACRS\">$Aclaris Therapeutics(ACRS)$</a>为什么put都是亏损？哪位大神指导一下","plainDigest":"$Aclaris Therapeutics(ACRS)$为什么put都是亏损？哪位大神指导一下","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1611176500566,"gmtModify":1703748612093,"symbols":["ACRS"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":0,"images":[],"repostCount":0,"viewCount":667,"likeCount":1,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/337496622","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":61,"authorId":"3547702836420032"}]},{"cardType":"TWEET","cardId":"TWEET.337409712","cardData":[{"tweetId":"337409712","author":{"authorId":"3530072543615030","name":"大韭菜盒子","avatar":"https://static.tigerbbs.com/a2277a8ca4e10763026e63aff57dad69","userType":1,"introduction":"","crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"digest":"<a href=\"https://laohu8.com/S/ACRS\">$Aclaris Therapeutics(ACRS)$</a>终于把价格打下来了","plainDigest":"$Aclaris Therapeutics(ACRS)$终于把价格打下来了","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1611168011036,"gmtModify":1703748592468,"symbols":["ACRS"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":0,"images":[],"repostCount":0,"viewCount":1445,"likeCount":2,"liked":false,"collected":false,"commentCount":2,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/337409712","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":45,"authorId":"3530072543615030"}]},{"cardType":"TWEET","cardId":"TWEET.337576091","cardData":[{"tweetId":"337576091","author":{"authorId":"3491195158027062","name":"阿呆的生活","avatar":"https://static.tigerbbs.com/3b007ec58e516664187144d950e3efc1","userType":1,"introduction":"","crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"digest":"<a href=\"https://laohu8.com/S/ACRS\">$Aclaris Therapeutics(ACRS)$</a>哟呼 半夜醒来瞅一眼 还没下去啊 还真是死犟死犟的啊","plainDigest":"$Aclaris Therapeutics(ACRS)$哟呼 半夜醒来瞅一眼 还没下去啊 还真是死犟死犟的啊","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1611165357013,"gmtModify":1703748583759,"symbols":["ACRS"],"themeIds":["5bfad02ab61749c8bfe6573ac7bbe8a3"],"themes":[{"themeId":"5bfad02ab61749c8bfe6573ac7bbe8a3","themeType":0,"name":"晒晒更赚钱"}],"popularizeThemeFlag":false,"imageCount":1,"images":[{"url":"https://static.tigerbbs.com/75bef2c152e2228845613452108d9c0e","width":"1242","height":"1767"}],"repostCount":0,"viewCount":1235,"likeCount":5,"liked":false,"collected":false,"commentCount":2,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/337576091","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":73,"authorId":"3491195158027062"}]},{"cardType":"TWEET","cardId":"TWEET.337588760","cardData":[{"tweetId":"337588760","author":{"authorId":"3530072543615030","name":"大韭菜盒子","avatar":"https://static.tigerbbs.com/a2277a8ca4e10763026e63aff57dad69","userType":1,"introduction":"","crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"digest":"<a href=\"https://laohu8.com/S/ACRS\">$Aclaris Therapeutics(ACRS)$</a>这庄家就跟我在这画图。","plainDigest":"$Aclaris Therapeutics(ACRS)$这庄家就跟我在这画图。","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1611158126450,"gmtModify":1703748514957,"symbols":["ACRS"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":0,"images":[],"repostCount":0,"viewCount":1203,"likeCount":1,"liked":false,"collected":false,"commentCount":6,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/337588760","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":48,"authorId":"3530072543615030"}]},{"cardType":"TWEET","cardId":"TWEET.337518877","cardData":[{"tweetId":"337518877","author":{"authorId":"3483669283508638","name":"我就是阿硕","avatar":"https://static.tigerbbs.com/ef3a6f12848da8815606073e69dae4be","userType":1,"introduction":"","crmLevel":8,"crmLevelSwitch":0,"individualDisplayBadges":[],"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"digest":"<a href=\"https://laohu8.com/S/ACRS\">$Aclaris Therapeutics(ACRS)$</a>搞不懂，今天高位直接增发呗！没人要吗？","plainDigest":"$Aclaris Therapeutics(ACRS)$搞不懂，今天高位直接增发呗！没人要吗？","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1611157368299,"gmtModify":1703748500588,"symbols":["ACRS"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":0,"images":[],"repostCount":0,"viewCount":1095,"likeCount":4,"liked":false,"collected":false,"commentCount":1,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/337518877","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":62,"authorId":"3483669283508638"}]},{"cardType":"TWEET","cardId":"TWEET.337596235","cardData":[{"tweetId":"337596235","author":{"authorId":"3570086755660930","name":"lvge","avatar":"https://static.tigerbbs.com/59d4c2168842cd24533a59aa21707b55","userType":1,"introduction":"","crmLevel":2,"crmLevelSwitch":1,"individualDisplayBadges":[],"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"digest":"<a href=\"https://laohu8.com/S/ACRS\">$Aclaris Therapeutics(ACRS)$</a>这是又不让睡了？","plainDigest":"$Aclaris Therapeutics(ACRS)$这是又不让睡了？","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1611156129927,"gmtModify":1703748473023,"symbols":["ACRS"],"themeIds":["5bfad02ab61749c8bfe6573ac7bbe8a3"],"themes":[{"themeId":"5bfad02ab61749c8bfe6573ac7bbe8a3","themeType":0,"name":"晒晒更赚钱"}],"popularizeThemeFlag":false,"imageCount":1,"images":[{"url":"https://static.tigerbbs.com/d178dcc450789b9b30dfa6c95187502a","width":"1080","height":"1920"}],"repostCount":0,"viewCount":1478,"likeCount":1,"liked":false,"collected":false,"commentCount":6,"hotComments":[{"id":"3358926","author":{"authorId":"3565866229126097","name":"韭菜小萌新","avatar":"https://static.tigerbbs.com/757150234f1e50e6d2ad5d4a78c6068d","userType":1,"introduction":"","crmLevel":2,"crmLevelSwitch":0,"starInvestorFlag":false},"content":"安心睡觉，猪已经被杀了，明天杀剩下不肯走的","plainContent":"安心睡觉，猪已经被杀了，明天杀剩下不肯走的","likeCount":0,"commentType":"valid","coins":0},{"id":"3358041","author":{"authorId":"3530072543615030","name":"大韭菜盒子","avatar":"https://static.tigerbbs.com/a2277a8ca4e10763026e63aff57dad69","userType":1,"introduction":"","crmLevel":1,"crmLevelSwitch":0,"starInvestorFlag":false},"content":"你这我睡的会很香","plainContent":"你这我睡的会很香","likeCount":0,"commentType":"valid","coins":0},{"id":"3357988","author":{"authorId":"3491195158027062","name":"阿呆的生活","avatar":"https://static.tigerbbs.com/3b007ec58e516664187144d950e3efc1","userType":1,"introduction":"","crmLevel":1,"crmLevelSwitch":0,"starInvestorFlag":false},"content":"睡去吧 这兄弟飞不了了","plainContent":"睡去吧 这兄弟飞不了了","likeCount":0,"commentType":"valid","coins":0}],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/337596235","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":42,"authorId":"3570086755660930"}]},{"cardType":"TWEET","cardId":"TWEET.337245582","cardData":[{"tweetId":"337245582","author":{"authorId":"3551316127379951","name":"ddddddddd","avatar":"https://static.tigerbbs.com/9057fa16019b7def5dddeec2e2c8140f","userType":1,"introduction":"","crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"digest":"<a href=\"https://laohu8.com/S/ACRS\">$Aclaris Therapeutics(ACRS)$</a>23.3再重仓空上，就不信你特么不会跌，有种给老子破50","plainDigest":"$Aclaris Therapeutics(ACRS)$23.3再重仓空上，就不信你特么不会跌，有种给老子破50","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1611154669846,"gmtModify":1703748435324,"symbols":["ACRS"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":0,"images":[],"repostCount":0,"viewCount":1439,"likeCount":0,"liked":false,"collected":false,"commentCount":1,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/337245582","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":75,"authorId":"3551316127379951"}]},{"cardType":"TWEET","cardId":"TWEET.337240451","cardData":[{"tweetId":"337240451","author":{"authorId":"3565866229126097","name":"韭菜小萌新","avatar":"https://static.tigerbbs.com/757150234f1e50e6d2ad5d4a78c6068d","userType":1,"introduction":"","crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[],"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"digest":"<a href=\"https://laohu8.com/S/ACRS\">$Aclaris Therapeutics(ACRS)$</a>小意思，做空从来没慌过[贱笑]&nbsp;[贱笑]&nbsp;[可爱]&nbsp;","plainDigest":"$Aclaris Therapeutics(ACRS)$小意思，做空从来没慌过[贱笑] [贱笑] [可爱]","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1611154334873,"gmtModify":1703748425390,"symbols":["ACRS"],"themeIds":["5bfad02ab61749c8bfe6573ac7bbe8a3"],"themes":[{"themeId":"5bfad02ab61749c8bfe6573ac7bbe8a3","themeType":0,"name":"晒晒更赚钱"}],"popularizeThemeFlag":false,"imageCount":1,"images":[{"url":"https://static.tigerbbs.com/81ab50cf18d70ca3e176da103aca23c4","width":"1080","height":"1920"}],"repostCount":0,"viewCount":836,"likeCount":3,"liked":false,"collected":false,"commentCount":4,"hotComments":[{"id":"3357957","author":{"authorId":"3570086755660930","name":"lvge","avatar":"https://static.tigerbbs.com/59d4c2168842cd24533a59aa21707b55","userType":1,"introduction":"","crmLevel":2,"crmLevelSwitch":1,"starInvestorFlag":false},"content":"为啥你是绿色，我是红色？","plainContent":"为啥你是绿色，我是红色？","likeCount":0,"commentType":"valid","coins":0}],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/337240451","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":66,"authorId":"3565866229126097"}]},{"cardType":"TWEET","cardId":"TWEET.337257211","cardData":[{"tweetId":"337257211","author":{"authorId":"3565866229126097","name":"韭菜小萌新","avatar":"https://static.tigerbbs.com/757150234f1e50e6d2ad5d4a78c6068d","userType":1,"introduction":"","crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[],"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"digest":"<a href=\"https://laohu8.com/S/ACRS\">$Aclaris Therapeutics(ACRS)$</a>坐收韭菜","plainDigest":"$Aclaris Therapeutics(ACRS)$坐收韭菜","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1611154295933,"gmtModify":1703748423152,"symbols":["ACRS"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":0,"images":[],"repostCount":0,"viewCount":345,"likeCount":1,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/337257211","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":35,"authorId":"3565866229126097"}]},{"cardType":"TWEET","cardId":"TWEET.337256895","cardData":[{"tweetId":"337256895","author":{"authorId":"3530072543615030","name":"大韭菜盒子","avatar":"https://static.tigerbbs.com/a2277a8ca4e10763026e63aff57dad69","userType":1,"introduction":"","crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"digest":"<a href=\"https://laohu8.com/S/ACRS\">$Aclaris Therapeutics(ACRS)$</a>趋势上看，回头难啊","plainDigest":"$Aclaris Therapeutics(ACRS)$趋势上看，回头难啊","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1611154114617,"gmtModify":1703748417493,"symbols":["ACRS"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":0,"images":[],"repostCount":0,"viewCount":267,"likeCount":1,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/337256895","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":44,"authorId":"3530072543615030"}]}],"size":20,"extra":{"requestId":"74fdc38f032149c6befab77adc306e36"}},"newsData":null,"noticeData":{"listData":[{"cdn_pdf":false,"hasAttachments":true,"id":"18110364","market":"us","media":"sec.gov","original_id":"AN155837024007069-ACRS","pdf_url":"","pub_time":1715054400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","symbol":"ACRS","title":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","titleType":"季度报告","type":"usFinancials","url":"https://www.sec.gov/Archives/edgar/data/1557746/000155837024007069/0001558370-24-007069-index.htm","us_notice_code":"Form 10-Q","us_title_en":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","is_important":1,"hasEarnInfos":false,"attachments":[{"description":"10-Q","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1557746/000155837024007069/acrs-20240331x10q.htm","primary":true,"translateUrl":"","linkName":"acrs-20240331x10q.htm","type":"10-Q","id":"NTFILE5rK5cJvKsUgUAxT9","market":"us","size":1404720},{"description":"EX-31.1","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1557746/000155837024007069/acrs-20240331xex31d1.htm","primary":false,"translateUrl":"","linkName":"acrs-20240331xex31d1.htm","type":"EX-31.1","id":"NTFILECjkJRZ7Xa3MNkLL5","market":"us","size":15615},{"description":"EX-31.2","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1557746/000155837024007069/acrs-20240331xex31d2.htm","primary":false,"translateUrl":"","linkName":"acrs-20240331xex31d2.htm","type":"EX-31.2","id":"NTFILE3DRQM2Q9JYkpiLzt","market":"us","size":15656},{"description":"EX-32.1","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1557746/000155837024007069/acrs-20240331xex32d1.htm","primary":false,"translateUrl":"","linkName":"acrs-20240331xex32d1.htm","type":"EX-32.1","id":"NTFILECgv2tcQQgWm5hzH6","market":"us","size":9518}],"type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Quarterly Report","us_type":"usFinancials","us_type_zh":"财务报告","earn_infos":[],"event_type":"important_notice","event_name":"季度报告","pubTime":"2024-05-07 12:00","pubTimestamp":1715054400,"title_zh":"Form 10-Q - Quarterly report [Sections 13 or 15(d","summary_en":"","summary_zh":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"18110148","market":"us","media":"sec.gov","original_id":"AN110465924057991-ACRS","pdf_url":"","pub_time":1715054400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form S-8 - Securities to be offered to employees in employee benefit plans","symbol":"ACRS","title":"Form S-8 - Securities to be offered to employees in employee benefit plans","titleType":"员工持股计划","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1557746/000110465924057991/0001104659-24-057991-index.htm","us_notice_code":"Form S-8","us_title_en":"Form S-8 - Securities to be offered to employees in employee benefit plans","is_important":1,"hasEarnInfos":false,"attachments":[{"description":"FORM S-8","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1557746/000110465924057991/tm2413675d1_s8.htm","primary":true,"translateUrl":"","linkName":"tm2413675d1_s8.htm","type":"S-8","id":"NTFILE37a2AAHhkVKMcynA","market":"us","size":46533},{"description":"EXHIBIT 5.1","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1557746/000110465924057991/tm2413675d1_ex5-1.htm","primary":false,"translateUrl":"","linkName":"tm2413675d1_ex5-1.htm","type":"EX-5.1","id":"NTFILECAJVkvZ9hDExcMkJ","market":"us","size":9086},{"description":"EXHIBIT 23.2","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1557746/000110465924057991/tm2413675d1_ex23-2.htm","primary":false,"translateUrl":"","linkName":"tm2413675d1_ex23-2.htm","type":"EX-23.2","id":"NTFILECUjKBcRDvpfU61qP","market":"us","size":2009},{"description":"EX-FILING FEES","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1557746/000110465924057991/tm2413675d1_ex-filingfees.htm","primary":false,"translateUrl":"","linkName":"tm2413675d1_ex-filingfees.htm","type":"EX-FILING FEES","id":"NTFILE7rimvLUMMLoLxiAt","market":"us","size":12574},{"description":"GRAPHIC","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1557746/000110465924057991/tm2413675d1_ex5-1img01.jpg","primary":false,"translateUrl":"","linkName":"tm2413675d1_ex5-1img01.jpg","type":"GRAPHIC","id":"NTFILE3Nqyxmfvgyn1SGUY","market":"us","size":10211}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Employee Stock Ownership","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"员工持股计划","pubTime":"2024-05-07 12:00","pubTimestamp":1715054400,"title_zh":"Form S-8 - Securities to be offered to employees in employee benefit plans","summary_en":"","summary_zh":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"18110138","market":"us","media":"sec.gov","original_id":"AN155837024007055-ACRS","pdf_url":"","pub_time":1715054400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"ACRS","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1557746/000155837024007055/0001558370-24-007055-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 2.02: Results of Operations and Financial Condition;\nItem 7.01: Regulation FD Disclosure;\nItem 9.01: Financial Statements and Exhibits","is_important":1,"hasEarnInfos":false,"attachments":[{"description":"EX-99.1","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1557746/000155837024007055/acrs-20240507xex99d1.htm","primary":true,"translateUrl":"","linkName":"acrs-20240507xex99d1.htm","type":"EX-99.1","id":"NTFILEAL18bm3DzS4DTb6Q","market":"us","size":135312},{"description":"8-K","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1557746/000155837024007055/acrs-20240507x8k.htm","primary":false,"translateUrl":"","linkName":"acrs-20240507x8k.htm","type":"8-K","id":"NTFILEHzmFHzfrU7dgRseM","market":"us","size":48189},{"description":"EX-99.2","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1557746/000155837024007055/acrs-20240507xex99d2.htm","primary":false,"translateUrl":"","linkName":"acrs-20240507xex99d2.htm","type":"EX-99.2","id":"NTFILE67R9NoTpbLNQAKdz","market":"us","size":37716},{"description":"GRAPHIC","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1557746/000155837024007055/acrs-20240507xex99d1001.jpg","primary":false,"translateUrl":"","linkName":"acrs-20240507xex99d1001.jpg","type":"GRAPHIC","id":"NTFILE2HFPvs13qEZVRuH5","market":"us","size":7805},{"description":"GRAPHIC","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1557746/000155837024007055/acrs-20240507xex99d2g001.jpg","primary":false,"translateUrl":"","linkName":"acrs-20240507xex99d2g001.jpg","type":"GRAPHIC","id":"NTFILEgW3QVs3wk2VzYMoe","market":"us","size":162466},{"description":"GRAPHIC","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1557746/000155837024007055/acrs-20240507xex99d2g002.jpg","primary":false,"translateUrl":"","linkName":"acrs-20240507xex99d2g002.jpg","type":"GRAPHIC","id":"NTFILEHxHcDHZ1vQ7ybDeH","market":"us","size":366940},{"description":"GRAPHIC","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1557746/000155837024007055/acrs-20240507xex99d2g003.jpg","primary":false,"translateUrl":"","linkName":"acrs-20240507xex99d2g003.jpg","type":"GRAPHIC","id":"NTFILE6Ksj3qWhqv3bw8BD","market":"us","size":92411},{"description":"GRAPHIC","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1557746/000155837024007055/acrs-20240507xex99d2g004.jpg","primary":false,"translateUrl":"","linkName":"acrs-20240507xex99d2g004.jpg","type":"GRAPHIC","id":"NTFILED4U8x8zvgZvJ9wRT","market":"us","size":216072},{"description":"GRAPHIC","seq":9,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1557746/000155837024007055/acrs-20240507xex99d2g005.jpg","primary":false,"translateUrl":"","linkName":"acrs-20240507xex99d2g005.jpg","type":"GRAPHIC","id":"NTFILECfM469FoRj2KbyDS","market":"us","size":163772},{"description":"GRAPHIC","seq":10,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1557746/000155837024007055/acrs-20240507xex99d2g006.jpg","primary":false,"translateUrl":"","linkName":"acrs-20240507xex99d2g006.jpg","type":"GRAPHIC","id":"NTFILE33vyyxtp98UCDvk3","market":"us","size":158157},{"description":"GRAPHIC","seq":11,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1557746/000155837024007055/acrs-20240507xex99d2g007.jpg","primary":false,"translateUrl":"","linkName":"acrs-20240507xex99d2g007.jpg","type":"GRAPHIC","id":"NTFILE2scD4VK44m1zxx4j","market":"us","size":157560},{"description":"GRAPHIC","seq":12,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1557746/000155837024007055/acrs-20240507xex99d2g008.jpg","primary":false,"translateUrl":"","linkName":"acrs-20240507xex99d2g008.jpg","type":"GRAPHIC","id":"NTFILEECvB5AdYCRdpxAW9","market":"us","size":181297},{"description":"GRAPHIC","seq":13,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1557746/000155837024007055/acrs-20240507xex99d2g009.jpg","primary":false,"translateUrl":"","linkName":"acrs-20240507xex99d2g009.jpg","type":"GRAPHIC","id":"NTFILEBQ3SPb88NN1yHdcb","market":"us","size":179284},{"description":"GRAPHIC","seq":14,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1557746/000155837024007055/acrs-20240507xex99d2g010.jpg","primary":false,"translateUrl":"","linkName":"acrs-20240507xex99d2g010.jpg","type":"GRAPHIC","id":"NTFILE9KkaAkiHWYdQDdoc","market":"us","size":149415},{"description":"GRAPHIC","seq":15,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1557746/000155837024007055/acrs-20240507xex99d2g011.jpg","primary":false,"translateUrl":"","linkName":"acrs-20240507xex99d2g011.jpg","type":"GRAPHIC","id":"NTFILEjLdBApNwGUmb86NS","market":"us","size":202039},{"description":"GRAPHIC","seq":16,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1557746/000155837024007055/acrs-20240507xex99d2g012.jpg","primary":false,"translateUrl":"","linkName":"acrs-20240507xex99d2g012.jpg","type":"GRAPHIC","id":"NTFILEAduMdx6VC882FX9C","market":"us","size":151137},{"description":"GRAPHIC","seq":17,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1557746/000155837024007055/acrs-20240507xex99d2g013.jpg","primary":false,"translateUrl":"","linkName":"acrs-20240507xex99d2g013.jpg","type":"GRAPHIC","id":"NTFILE4Y7vuiiyknuHFcy1","market":"us","size":200958},{"description":"GRAPHIC","seq":18,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1557746/000155837024007055/acrs-20240507xex99d2g014.jpg","primary":false,"translateUrl":"","linkName":"acrs-20240507xex99d2g014.jpg","type":"GRAPHIC","id":"NTFILE4ScEg9bbp8wuAdDb","market":"us","size":192389},{"description":"GRAPHIC","seq":19,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1557746/000155837024007055/acrs-20240507xex99d2g015.jpg","primary":false,"translateUrl":"","linkName":"acrs-20240507xex99d2g015.jpg","type":"GRAPHIC","id":"NTFILECzF1HmsPB6a7vvwP","market":"us","size":213347},{"description":"GRAPHIC","seq":20,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1557746/000155837024007055/acrs-20240507xex99d2g016.jpg","primary":false,"translateUrl":"","linkName":"acrs-20240507xex99d2g016.jpg","type":"GRAPHIC","id":"NTFILEA1Pzxc8qHv2k9LeF","market":"us","size":115193},{"description":"GRAPHIC","seq":21,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1557746/000155837024007055/acrs-20240507xex99d2g017.jpg","primary":false,"translateUrl":"","linkName":"acrs-20240507xex99d2g017.jpg","type":"GRAPHIC","id":"NTFILEHbunF6jFWgnwcHva","market":"us","size":220715},{"description":"GRAPHIC","seq":22,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1557746/000155837024007055/acrs-20240507xex99d2g018.jpg","primary":false,"translateUrl":"","linkName":"acrs-20240507xex99d2g018.jpg","type":"GRAPHIC","id":"NTFILEGW1Ar1rxh7ki4qGQ","market":"us","size":70607},{"description":"GRAPHIC","seq":23,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1557746/000155837024007055/acrs-20240507xex99d2g019.jpg","primary":false,"translateUrl":"","linkName":"acrs-20240507xex99d2g019.jpg","type":"GRAPHIC","id":"NTFILEHmVu64V56uMSXfwV","market":"us","size":181854},{"description":"GRAPHIC","seq":24,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1557746/000155837024007055/acrs-20240507xex99d2g020.jpg","primary":false,"translateUrl":"","linkName":"acrs-20240507xex99d2g020.jpg","type":"GRAPHIC","id":"NTFILE3fDCAEpWGJDnVtvH","market":"us","size":169753},{"description":"GRAPHIC","seq":25,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1557746/000155837024007055/acrs-20240507xex99d2g021.jpg","primary":false,"translateUrl":"","linkName":"acrs-20240507xex99d2g021.jpg","type":"GRAPHIC","id":"NTFILE58iMqxpbSQn7mKoj","market":"us","size":135778},{"description":"GRAPHIC","seq":26,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1557746/000155837024007055/acrs-20240507xex99d2g022.jpg","primary":false,"translateUrl":"","linkName":"acrs-20240507xex99d2g022.jpg","type":"GRAPHIC","id":"NTFILE9W6js65EaeXVkbQ8","market":"us","size":162466}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2024-05-07 12:00","pubTimestamp":1715054400,"title_zh":"Form 8-K - Current report","summary_en":"Item 2.02: Results of Operations and Financial Condition;\nItem 7.01: Regulation FD Disclosure;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"第2.02项：经营成果和财务状况；第7.01项：法规FD披露；项目9.01：财务报表和附件","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"17725983","market":"us","media":"sec.gov","original_id":"AN155837024003572-ACRS","pdf_url":"","pub_time":1710820800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"ACRS","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1557746/000155837024003572/0001558370-24-003572-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers","is_important":1,"hasEarnInfos":false,"attachments":[{"description":"8-K","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1557746/000155837024003572/acrs-20240314x8k.htm","primary":true,"translateUrl":"","linkName":"acrs-20240314x8k.htm","type":"8-K","id":"NTFILE4X2km2Z5xgH8YK4y","market":"us","size":36084}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2024-03-19 12:00","pubTimestamp":1710820800,"title_zh":"Form 8-K - Current report","summary_en":"Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers","summary_zh":"第5.02项：董事或某些高级职员离职；选举董事；若干高级职员的委任：若干高级职员的补偿安排","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"17639351","market":"us","media":"sec.gov","original_id":"AN155837024001753-ACRS","pdf_url":"","pub_time":1709010000000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]","symbol":"ACRS","title":"Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]","titleType":"年度报告","type":"usFinancials","url":"https://www.sec.gov/Archives/edgar/data/1557746/000155837024001753/0001558370-24-001753-index.htm","us_notice_code":"Form 10-K","us_title_en":"Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]","is_important":1,"hasEarnInfos":false,"attachments":[{"description":"10-K","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1557746/000155837024001753/acrs-20231231x10k.htm","primary":true,"translateUrl":"","linkName":"acrs-20231231x10k.htm","type":"10-K","id":"NTFILE2HYzq3pginNtokd1","market":"us","size":2747418},{"description":"EX-4.1","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1557746/000155837024001753/acrs-20231231xex4d1.htm","primary":false,"translateUrl":"","linkName":"acrs-20231231xex4d1.htm","type":"EX-4.1","id":"NTFILE2kLa7F9BmsasvFqJ","market":"us","size":25437},{"description":"EX-10.15","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1557746/000155837024001753/acrs-20231231xex10d15.htm","primary":false,"translateUrl":"","linkName":"acrs-20231231xex10d15.htm","type":"EX-10.15","id":"NTFILE3smCL5LQsCeix1jU","market":"us","size":119404},{"description":"EX-10.18","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1557746/000155837024001753/acrs-20231231xex10d18.htm","primary":false,"translateUrl":"","linkName":"acrs-20231231xex10d18.htm","type":"EX-10.18","id":"NTFILEHkrV8TTCXSKn2Mbq","market":"us","size":87471},{"description":"EX-10.22","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1557746/000155837024001753/acrs-20231231xex10d22.htm","primary":false,"translateUrl":"","linkName":"acrs-20231231xex10d22.htm","type":"EX-10.22","id":"NTFILE8f8q93CyuxgDokAD","market":"us","size":27599},{"description":"EX-21.1","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1557746/000155837024001753/acrs-20231231xex21d1.htm","primary":false,"translateUrl":"","linkName":"acrs-20231231xex21d1.htm","type":"EX-21.1","id":"NTFILE5HZt56mR8nJ7PQTE","market":"us","size":5806},{"description":"EX-23.1","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1557746/000155837024001753/acrs-20231231xex23d1.htm","primary":false,"translateUrl":"","linkName":"acrs-20231231xex23d1.htm","type":"EX-23.1","id":"NTFILEBRasUcoehRcYqxH4","market":"us","size":2657},{"description":"EX-31.1","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1557746/000155837024001753/acrs-20231231xex31d1.htm","primary":false,"translateUrl":"","linkName":"acrs-20231231xex31d1.htm","type":"EX-31.1","id":"NTFILEByM1V5dShQ2j3bdL","market":"us","size":9675},{"description":"EX-31.2","seq":9,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1557746/000155837024001753/acrs-20231231xex31d2.htm","primary":false,"translateUrl":"","linkName":"acrs-20231231xex31d2.htm","type":"EX-31.2","id":"NTFILE9NAqjDsBU65x5p38","market":"us","size":9768},{"description":"EX-32.1","seq":10,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1557746/000155837024001753/acrs-20231231xex32d1.htm","primary":false,"translateUrl":"","linkName":"acrs-20231231xex32d1.htm","type":"EX-32.1","id":"NTFILECa8d2zZj6aeE6LLh","market":"us","size":9261},{"description":"EX-97.1","seq":11,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1557746/000155837024001753/acrs-20231231xex97d1.htm","primary":false,"translateUrl":"","linkName":"acrs-20231231xex97d1.htm","type":"EX-97.1","id":"NTFILE573HH6zcdMAu3s1e","market":"us","size":38497},{"description":"GRAPHIC","seq":12,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1557746/000155837024001753/acrs-20231231x10k002.jpg","primary":false,"translateUrl":"","linkName":"acrs-20231231x10k002.jpg","type":"GRAPHIC","id":"NTFILEEVPYp7QAQStjdYYy","market":"us","size":41449},{"description":"GRAPHIC","seq":13,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1557746/000155837024001753/acrs-20231231xex10d22003.jpg","primary":false,"translateUrl":"","linkName":"acrs-20231231xex10d22003.jpg","type":"GRAPHIC","id":"NTFILE2TUJoDXdvdTtDKjm","market":"us","size":12332}],"type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Annual Report","us_type":"usFinancials","us_type_zh":"财务报告","earn_infos":[],"event_type":"important_notice","event_name":"年度报告","pubTime":"2024-02-27 13:00","pubTimestamp":1709010000,"title_zh":"Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405","summary_en":"","summary_zh":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"17639308","market":"us","media":"sec.gov","original_id":"AN155837024001752-ACRS","pdf_url":"","pub_time":1709010000000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"ACRS","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1557746/000155837024001752/0001558370-24-001752-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 2.02: Results of Operations and Financial Condition;\nItem 9.01: Financial Statements and Exhibits","is_important":1,"hasEarnInfos":false,"attachments":[{"description":"EX-99.1","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1557746/000155837024001752/acrs-20240227xex99d1.htm","primary":true,"translateUrl":"","linkName":"acrs-20240227xex99d1.htm","type":"EX-99.1","id":"NTFILEEq31ns94nTCKQ7JT","market":"us","size":214216},{"description":"8-K","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1557746/000155837024001752/acrs-20240227x8k.htm","primary":false,"translateUrl":"","linkName":"acrs-20240227x8k.htm","type":"8-K","id":"NTFILEA1THhoz5XDr46wuA","market":"us","size":45022},{"description":"GRAPHIC","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1557746/000155837024001752/acrs-20240227xex99d1001.jpg","primary":false,"translateUrl":"","linkName":"acrs-20240227xex99d1001.jpg","type":"GRAPHIC","id":"NTFILEF5E6e5nvCLqJT8rw","market":"us","size":7805}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2024-02-27 13:00","pubTimestamp":1709010000,"title_zh":"Form 8-K - Current report","summary_en":"Item 2.02: Results of Operations and Financial Condition;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"第2.02项：经营成果和财务状况；项目9.01：财务报表和附件","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"17599993","market":"us","media":"sec.gov","original_id":"AN110465924023983-ACRS","pdf_url":"","pub_time":1707886800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]","symbol":"ACRS","title":"Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]","titleType":"超过5%披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1557746/000110465924023983/0001104659-24-023983-index.htm","us_notice_code":"Form SC 13G/A","us_title_en":"Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]","is_important":1,"hasEarnInfos":false,"attachments":[{"description":"SC 13G/A","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1346824/000110465924023983/tm245429d10_sc13ga.htm","primary":true,"translateUrl":"","linkName":"tm245429d10_sc13ga.htm","type":"SC 13G/A","id":"NTFILEF7WhZFAa5JCGrqzc","market":"us","size":85495}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Beneficial Ownership Change","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"超过5%披露","pubTime":"2024-02-14 13:00","pubTimestamp":1707886800,"title_zh":"Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend","summary_en":"","summary_zh":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"17599990","market":"us","media":"sec.gov","original_id":"AN110465924024206-ACRS","pdf_url":"","pub_time":1707886800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]","symbol":"ACRS","title":"Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]","titleType":"超过5%披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1557746/000110465924024206/0001104659-24-024206-index.htm","us_notice_code":"Form SC 13G/A","us_title_en":"Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]","is_important":1,"hasEarnInfos":false,"attachments":[{"description":"SC 13G/A","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1557746/000110465924024206/tm246235d22_sc13ga.htm","primary":true,"translateUrl":"","linkName":"tm246235d22_sc13ga.htm","type":"SC 13G/A","id":"NTFILEAbf1aJCJXPo8GMuR","market":"us","size":215539}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Beneficial Ownership Change","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"超过5%披露","pubTime":"2024-02-14 13:00","pubTimestamp":1707886800,"title_zh":"Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend","summary_en":"","summary_zh":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"17599364","market":"us","media":"sec.gov","original_id":"AN110465924023946-ACRS","pdf_url":"","pub_time":1707886800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]","symbol":"ACRS","title":"Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]","titleType":"超过5%披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1557746/000110465924023946/0001104659-24-023946-index.htm","us_notice_code":"Form SC 13G/A","us_title_en":"Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]","is_important":1,"hasEarnInfos":false,"attachments":[{"description":"SC 13G/A","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1423053/000110465924023946/tm243953d11_sc13ga.htm","primary":true,"translateUrl":"","linkName":"tm243953d11_sc13ga.htm","type":"SC 13G/A","id":"NTFILE3rq2PbwU4hZjpTYy","market":"us","size":135933}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Beneficial Ownership Change","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"超过5%披露","pubTime":"2024-02-14 13:00","pubTimestamp":1707886800,"title_zh":"Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend","summary_en":"","summary_zh":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"17598840","market":"us","media":"sec.gov","original_id":"AN127308724000046-ACRS","pdf_url":"","pub_time":1707886800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form SC 13G - Statement of acquisition of beneficial ownership by individuals","symbol":"ACRS","title":"Form SC 13G - Statement of acquisition of beneficial ownership by individuals","titleType":"超过5%披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1557746/000127308724000046/0001273087-24-000046-index.htm","us_notice_code":"Form SC 13G","us_title_en":"Form SC 13G - Statement of acquisition of beneficial ownership by individuals","is_important":1,"hasEarnInfos":false,"attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1273087/000127308724000046/ACRS_SC13G_Feb24.htm","primary":true,"translateUrl":"","linkName":"ACRS_SC13G_Feb24.htm","type":"SC 13G","id":"NTFILE95FcEi6risac1e4J","market":"us","size":79899}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Beneficial Ownership Change","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"超过5%披露","pubTime":"2024-02-14 13:00","pubTimestamp":1707886800,"title_zh":"Form SC 13G - Statement of acquisition of beneficial ownership by individuals","summary_en":"","summary_zh":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"17598836","market":"us","media":"sec.gov","original_id":"AN121465924002856-ACRS","pdf_url":"","pub_time":1707886800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]","symbol":"ACRS","title":"Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]","titleType":"超过5%披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1557746/000121465924002856/0001214659-24-002856-index.htm","us_notice_code":"Form SC 13G/A","us_title_en":"Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]","is_important":1,"hasEarnInfos":false,"attachments":[{"description":"AMENDMENT NO. 1","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1191935/000121465924002856/b110242sc13ga1.htm","primary":true,"translateUrl":"","linkName":"b110242sc13ga1.htm","type":"SC 13G/A","id":"NTFILE6rNZUJZEVEhbaLss","market":"us","size":82803}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Beneficial Ownership Change","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"超过5%披露","pubTime":"2024-02-14 13:00","pubTimestamp":1707886800,"title_zh":"Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend","summary_en":"","summary_zh":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"17598000","market":"us","media":"sec.gov","original_id":"AN117266124001203-ACRS","pdf_url":"","pub_time":1707886800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]","symbol":"ACRS","title":"Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]","titleType":"超过5%披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1557746/000117266124001203/0001172661-24-001203-index.htm","us_notice_code":"Form SC 13G/A","us_title_en":"Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]","is_important":1,"hasEarnInfos":false,"attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1557746/000117266124001203/rocksprings-acrs123123a4.htm","primary":true,"translateUrl":"","linkName":"rocksprings-acrs123123a4.htm","type":"SC 13G/A","id":"NTFILEQuy2tvZtV3fxHQpt","market":"us","size":108562}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Beneficial Ownership Change","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"超过5%披露","pubTime":"2024-02-14 13:00","pubTimestamp":1707886800,"title_zh":"Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend","summary_en":"","summary_zh":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"17597034","market":"us","media":"sec.gov","original_id":"AN92189524000465-ACRS","pdf_url":"","pub_time":1707886800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]","symbol":"ACRS","title":"Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]","titleType":"超过5%披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1557746/000092189524000465/0000921895-24-000465-index.htm","us_notice_code":"Form SC 13G/A","us_title_en":"Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]","is_important":1,"hasEarnInfos":false,"attachments":[{"description":"AMENDMENT NO. 1 TO SCHEDULE 13G","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/918923/000092189524000465/sc13ga107422acrs_02142024.htm","primary":true,"translateUrl":"","linkName":"sc13ga107422acrs_02142024.htm","type":"SC 13G/A","id":"NTFILECbMxsbePvyWqtafu","market":"us","size":264660}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Beneficial Ownership Change","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"超过5%披露","pubTime":"2024-02-14 13:00","pubTimestamp":1707886800,"title_zh":"Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend","summary_en":"","summary_zh":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"17592073","market":"us","media":"sec.gov","original_id":"AN110465924020170-ACRS","pdf_url":"","pub_time":1707861355000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form SC 13G - Statement of acquisition of beneficial ownership by individuals","symbol":"ACRS","title":"Form SC 13G - Statement of acquisition of beneficial ownership by individuals","titleType":"超过5%披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1557746/0001104659-24-020170-index.html","us_notice_code":"Form SC 13G","us_title_en":"Form SC 13G - Statement of acquisition of beneficial ownership by individuals","is_important":1,"hasEarnInfos":false,"attachments":[{"description":"SCHEDULE 13G","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/102909/000110465924020170/tv0177-aclaristherapeuticsin.htm","primary":true,"translateUrl":"","linkName":"tv0177-aclaristherapeuticsin.htm","type":"SC 13G","id":"NTFILEAmrsYThA4o2wmYZK","market":"us","size":11449}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Beneficial Ownership Change","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"超过5%披露","pubTime":"2024-02-14 05:55","pubTimestamp":1707861355,"title_zh":"Form SC 13G - Statement of acquisition of beneficial ownership by individuals","summary_en":"","summary_zh":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"17590002","market":"us","media":"sec.gov","original_id":"AN110465924019725-ACRS","pdf_url":"","pub_time":1707800400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]","symbol":"ACRS","title":"Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]","titleType":"超过5%披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1557746/000110465924019725/0001104659-24-019725-index.htm","us_notice_code":"Form SC 13G/A","us_title_en":"Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]","is_important":1,"hasEarnInfos":false,"attachments":[{"description":"SC 13G/A","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1557746/000110465924019725/tm245717d2_sc13ga.htm","primary":true,"translateUrl":"","linkName":"tm245717d2_sc13ga.htm","type":"SC 13G/A","id":"NTFILEBQgV2yNNhgQ1Geoa","market":"us","size":90260}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Beneficial Ownership Change","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"超过5%披露","pubTime":"2024-02-13 13:00","pubTimestamp":1707800400,"title_zh":"Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend","summary_en":"","summary_zh":"","gpt_icon":0}],"currentPage":1,"bottom":false},"companyData":{"profile":{"websiteUrl":"http://www.aclaristx.com","stockEarnings":[{"period":"1week","weight":-0.0367},{"period":"1month","weight":-0.0328},{"period":"3month","weight":-0.0084},{"period":"6month","weight":0.2365},{"period":"1year","weight":-0.858},{"period":"ytd","weight":0.1238}],"compareEarnings":[{"period":"1week","weight":0.0164},{"period":"1month","weight":0.05},{"period":"3month","weight":0.0584},{"period":"6month","weight":0.1728},{"period":"1year","weight":0.2732},{"period":"ytd","weight":0.1123}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Aclaris Therapeutics, Inc.于2012年7月在美国特拉华州成立。该公司是一家临床阶段的生物制药公司，专注于开发免疫炎症疾病的新型候选药物。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":0.159429},{"month":2,"riseRate":0.444444,"avgChangeRate":-0.00511},{"month":3,"riseRate":0.444444,"avgChangeRate":-0.035243},{"month":4,"riseRate":0.444444,"avgChangeRate":-0.000298},{"month":5,"riseRate":0.444444,"avgChangeRate":-0.040747},{"month":6,"riseRate":0.625,"avgChangeRate":-0.011266},{"month":7,"riseRate":0.5,"avgChangeRate":-0.024457},{"month":8,"riseRate":0.5,"avgChangeRate":-0.042275},{"month":9,"riseRate":0.5,"avgChangeRate":0.038413},{"month":10,"riseRate":0.25,"avgChangeRate":0.052818},{"month":11,"riseRate":0.222222,"avgChangeRate":-0.060376},{"month":12,"riseRate":0.777778,"avgChangeRate":0.149317}],"exchange":"NASDAQ","name":"Aclaris Therapeutics","nameEN":"Aclaris Therapeutics"},"aProfile":null}}}